Log In
BCIQ
Print this Print this
 

shIDO-ST

  Manage Alerts
Collapse Summary General Information
Company City of Hope
DescriptionModified <i>salmonella</i>-based bacterium targeting indoleamine 2,3-dioxygenase (INDO; IDO) combined with PEGPH20, a recombinant human PH20 hyaluronidase enzyme conjugated to polyethylene glycol
Molecular Target Indoleamine 2,3-dioxygenase (INDO) (IDO) ; Hyaluronan
Mechanism of ActionIndoleamine 2,3-dioxygenase (INDO) inhibitor; Degrades hyaluronan
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic ductal adenocarcinoma (PDA)
Regulatory Designation
PartnerTara Immuno-Oncology LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$10.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/03/2015

$10.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today